Caris Life Sciences, Inc. (CAI) stock
CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3084% above fair value
$18.54−0.96 (-4.92%)
Close on Nov 19, 2026Market cap $5.24BP/E –Yield –
Caris Life Sciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Caris Life Sciences's shares outstanding was 295M at Sep 30, 2026. For fiscal 2025 it was 167M, up 371.0% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 167M | +371.0% |
| FY2024 | Dec 31, 2024 | 35M | +1.6% |
| FY2023 | Dec 31, 2023 | 35M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 295M | -0.7% |
| Q2 FY2026 | Jun 30, 2026 | 283M | +335.8% |
| Q1 FY2026 | Mar 31, 2026 | 283M | +693.2% |
| Q4 FY2025 | Dec 31, 2025 | 283M | +695.0% |
| Q3 FY2025 | Sep 30, 2025 | 297M | +733.8% |
| Q2 FY2025 | Jun 30, 2025 | 65M | +83.5% |
| Q1 FY2025 | Mar 31, 2025 | 36M | – |
| Q4 FY2024 | Dec 31, 2024 | 36M | – |
| Q3 FY2024 | Sep 30, 2024 | 36M | – |
| Q2 FY2024 | Jun 30, 2024 | 35M | – |
See a number that looks wrong?